強気
$310.11
シナリオ価格
$310.340
-7.293 (-2.35%)終値時点
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution.
Veeva Systems Inc is a good buy right now, with a current price of $323.04 and a strong RSI of 84.127 indicating overbought conditions but also strong momentum. The forward P/E ratio is 30.21, suggesting growth potential, and the gross margin is robust at 75.41%. The main risk is the high P/E ratio of 51.46, which indicates that the stock is priced for significant growth, and any failure to meet growth expectations could lead to a price correction.
Mizuho
$345
2026-10-29
Mizuho
2026-10-29
目標株価
$345
Baird
$350
2026-10-26
Baird
2026-10-26
目標株価
$350
Wells Fargo
$330
2026-09-08
Wells Fargo
2026-09-08
目標株価
$330
Citi
$273
2026-08-28
Citi
2026-08-28
目標株価
$273
Truist
$305
2026-08-27
Truist
2026-08-27
目標株価
$305
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Veeva Commercial Summit Highlights AI-Driven Customer Engagement Strategies

Veeva Summit Highlights Innovations in Life Sciences

Veeva Summit Highlights Biopharma Innovations

Veeva Commercial Summit Highlights Medical Innovation Strategies

Biotech IPO Market Shows Signs of Recovery
Veeva Systems Inc. provides cloud solutions for the global life sciences industry. The Company offers cloud software, artificial intelligence (AI), data, and business consulting and is designed to meet the needs of its customers and their strategic business functions, from research and development through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud comprises software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences. It also provides Veeva Falcon MLR, an agentic MLR solution. It operates in the Healthcare sector (SERVICES-PREPACKAGED SOFTWARE industry).
Veeva Systems Inc is a good buy right now, with a current price of $323.04 and a strong RSI of 84.127 indicating overbought conditions but also strong momentum. The forward P/E ratio is 30.21, suggesting growth potential, and the gross margin is robust at 75.41%. The main risk is the high P/E ratio of 51.46, which indicates that the stock is priced for significant growth, and any failure to meet growth expectations could lead to a price correction.
14 analysts cover VEEV: 8 rate it Buy, 6 Hold and 0 Sell. The average price target is 317.10.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。